{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:28:56Z","timestamp":1769023736585,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>\n              <jats:italic>Campylobacter jejuni<\/jats:italic> is the predominant cause of antecedent infection in post-infectious neuropathies such as the Guillain-Barr\u00e9 (GBS) and Miller Fisher syndromes (MFS). GBS and MFS are probably induced by molecular mimicry between human gangliosides and bacterial lipo-oligosaccharides (LOS). This study describes a new <jats:italic>C. jejuni<\/jats:italic>-specific high-throughput AFLP (htAFLP) approach for detection and identification of DNA polymorphism, in general, and of putative GBS\/MFS-markers, in particular.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We compared 6 different isolates of the \"genome strain\" NCTC 11168 obtained from different laboratories. HtAFLP analysis generated approximately 3000 markers per stain, 19 of which were polymorphic. The DNA polymorphisms could not be confirmed by PCR-RFLP analysis, suggesting a baseline level of 0.6% AFLP artefacts. Comparison of NCTC 11168 with 4 GBS-associated strains revealed 23 potentially GBS-specific markers, 17 of which were identified by DNA sequencing. A collection of 27 GBS\/MFS-associated and 17 enteritis control strains was analyzed with PCR-RFLP tests based on 11 of these markers. We identified 3 markers, located in the LOS biosynthesis genes cj1136, cj1138 and cj1139c, that were significantly associated with GBS (P = 0.024, P = 0.047 and P &lt; 0.001, respectively). HtAFLP analysis of 13 highly clonal South African GBS\/MFS-associated and enteritis control strains did not reveal GBS-specific markers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study shows that bacterial GBS markers are limited in number and located in the LOS biosynthesis genes, which corroborates the current consensus that LOS mimicry may be the prime etiologic determinant of GBS. Furthermore, our results demonstrate that htAFLP, with its high reproducibility and resolution, is an effective technique for the detection and subsequent identification of putative bacterial disease markers.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2180-6-32","type":"journal-article","created":{"date-parts":[[2006,4,20]],"date-time":"2006-04-20T14:19:38Z","timestamp":1145542778000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Identification of DNA sequence variation in Campylobacter jejuni strains associated with the Guillain-Barr\u00e9 syndrome by high-throughput AFLP analysis"],"prefix":"10.1186","volume":"6","author":[{"given":"Peggy CR","family":"Godschalk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathijs P","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond FJ","family":"Gorkink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guus","family":"Simons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"van den Braak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert J","family":"Lastovica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubert P","family":"Endtz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henri A","family":"Verbrugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"van Belkum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,4,4]]},"reference":[{"key":"245_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1056\/NEJM195607122550201","volume":"255","author":"M Fisher","year":"1956","unstructured":"Fisher M: An unusual variant of acute idiopathic polyneuritis: syndrome of ophthalmoplegia, ataxia and areflexia. N Engl J Med. 1956, 255: 57-65.","journal-title":"N Engl J Med"},{"key":"245_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1473-3099(01)00019-6","volume":"1","author":"N Yuki","year":"2001","unstructured":"Yuki N: Infectious origins of, and molecular mimicry in, Guillain-Barr\u00e9 and Fisher syndromes. Lancet Infect Dis. 2001, 1: 29-37. 10.1016\/S1473-3099(01)00019-6.","journal-title":"Lancet Infect Dis"},{"key":"245_CR3","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","volume":"51","author":"BC Jacobs","year":"1998","unstructured":"Jacobs BC, Rothbarth PH, van der Mech\u00e9 FGA, Herbrink P, Schmitz PIM, De Klerk MA, van Doorn PA: The spectrum of antecedent infections in Guillain-Barr\u00e9 syndrome: a case-control study. Neurology. 1998, 51: 1110-1115.","journal-title":"Neurology"},{"key":"245_CR4","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1136\/jnnp.51.5.613","volume":"51","author":"JB Winer","year":"1988","unstructured":"Winer JB, Hughes RAC, Anderson MJ, Jones DM, Kangro H, Watkins RP: A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry. 1988, 51: 613-618.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"245_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S1286-4579(02)01553-8","volume":"4","author":"I Nachamkin","year":"2002","unstructured":"Nachamkin I: Chronic effects of Campylobacter infection. Microbes Infect. 2002, 4: 399-403. 10.1016\/S1286-4579(02)01553-8.","journal-title":"Microbes Infect"},{"key":"245_CR6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1179\/096805100101532270","volume":"6","author":"MM Prendergast","year":"2000","unstructured":"Prendergast MM, Moran AP: Lipopolysaccharides in the development of the Guillain-Barr\u00e9 syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies. J Endotoxin Res. 2000, 6: 341-359. 10.1179\/096805100101532270.","journal-title":"J Endotoxin Res"},{"key":"245_CR7","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/aje\/153.6.610","volume":"153","author":"N McCarthy","year":"2001","unstructured":"McCarthy N, Giesecke J: Incidence of Guillain-Barr\u00e9 syndrome following infection with Campylobacter jejuni. Am J Epidemiol. 2001, 153: 610-614. 10.1093\/aje\/153.6.610.","journal-title":"Am J Epidemiol"},{"key":"245_CR8","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.1086\/513783","volume":"176","author":"B Mishu Allos","year":"1997","unstructured":"Mishu Allos B: Association between Campylobacter infection and Guillain-Barr\u00e9 syndrome. J Infect Dis. 1997, 176: S125-128.","journal-title":"J Infect Dis"},{"key":"245_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/ana.410330304","volume":"33","author":"S Kuroki","year":"1993","unstructured":"Kuroki S, Saida T, Nukina M, Haruta T, Yoshioka M, Kobayashi Y, Nakanishi H: Campylobacter jejuni strains from patients with Guillain-Barr\u00e9 syndrome belong mostly to Penner serogroup 19 and contain beta-N-acetylglucosamine residues. Ann Neurol. 1993, 33: 243-247. 10.1002\/ana.410330304.","journal-title":"Ann Neurol"},{"key":"245_CR10","doi-asserted-by":"publisher","first-page":"S139","DOI":"10.1086\/513796","volume":"176","author":"AJ Lastovica","year":"1997","unstructured":"Lastovica AJ, Goddard EA, Argent AC: Guillain-Barr\u00e9 syndrome in South Africa associated with Campylobacter jejuni O:41 strains. J Infect Dis. 1997, 176: S139-143.","journal-title":"J Infect Dis"},{"key":"245_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1086\/322008","volume":"184","author":"I Nachamkin","year":"2001","unstructured":"Nachamkin I, Engberg J, Gutacker M, Meinersman RJ, Li CY, Arzate P, Teeple E, Fussing V, Ho TW, Asbury AK, Griffin JW, McKhann GM, Piffaretti JC: Molecular population genetic analysis of Campylobacter jejuni HS:19 associated with Guillain-Barre syndrome and gastroenteritis. J Infect Dis. 2001, 184: 221-226. 10.1086\/322008.","journal-title":"J Infect Dis"},{"key":"245_CR12","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1128\/JCM.38.2.874-876.2000","volume":"38","author":"TM Wassenaar","year":"2000","unstructured":"Wassenaar TM, Fry BN, Lastovica AJ, Wagenaar JA, Coloe PJ, Duim B: Genetic characterization of Campylobacter jejuni O:41 isolates in relation with Guillain-Barr\u00e9 syndrome. J Clin Microbiol. 2000, 38: 874-876.","journal-title":"J Clin Microbiol"},{"key":"245_CR13","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1046\/j.1365-2958.2000.01717.x","volume":"35","author":"AV Karlyshev","year":"2000","unstructured":"Karlyshev AV, Linton D, Gregson NA, Lastovica AJ, Wren BW: Genetic and biochemical evidence of a Campylobacter jejuni capsular polysaccharide that accounts for Penner serotype specificity. Mol Microbiol. 2000, 35: 529-541. 10.1046\/j.1365-2958.2000.01717.x.","journal-title":"Mol Microbiol"},{"key":"245_CR14","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1128\/JCM.38.6.2297-2301.2000","volume":"38","author":"HP Endtz","year":"2000","unstructured":"Endtz HP, Ang CW, van den Braak N, Duim B, Rigter A, Price LJ, Woodward DL, Rodgers FG, Johnson WM, Wagenaar JA, Jacobs BC, Verbrugh HA, van Belkum A: Molecular characterization of Campylobacter jejuni from patients with Guillain-Barr\u00e9 and Miller Fisher syndromes. J Clin Microbiol. 2000, 38: 2297-2301.","journal-title":"J Clin Microbiol"},{"key":"245_CR15","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1128\/JCM.39.9.3346-3349.2001","volume":"39","author":"KE Dingle","year":"2001","unstructured":"Dingle KE, van den Braak N, Colles FM, Price LJ, Woodward DL, Rodgers FG, Endtz HP, van Belkum A, Maiden MCJ: Sequence typing confirms that Campylobacter jejuni strains associated with Guillain-Barr\u00e9 and Miller Fisher syndromes are of diverse genetic lineage, serotype and flagella type. J Clin Microbiol. 2001, 39: 3346-3349. 10.1128\/JCM.39.9.3346-3349.2001.","journal-title":"J Clin Microbiol"},{"key":"245_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1086\/322010","volume":"184","author":"J Engberg","year":"2001","unstructured":"Engberg J, Nachamkin I, Fussing V, McKhann GM, Griffin JW, Piffaretti JC, Nielsen EM, Gerner-Smidt P: Absence of clonality of Campylobacter jejuni in serotypes other than HS:19 associated with Guillain-Barr\u00e9 syndrome and gastroenteritis. J Infect Dis. 2001, 184: 215-220. 10.1086\/322010.","journal-title":"J Infect Dis"},{"key":"245_CR17","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1086\/516522","volume":"176","author":"S Fujimoto","year":"1997","unstructured":"Fujimoto S, Allos BM, Misawa N, Patton CM, Blaser MJ: Restriction fragment length polymorphism analysis and random amplified polymorphic DNA analysis of Campylobacter jejuni strains isolated from patients with Guillain-Barr\u00e9 syndrome. J Infect Dis. 1997, 176: 1105-1108.","journal-title":"J Infect Dis"},{"key":"245_CR18","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1128\/IAI.72.2.1199-1203.2004","volume":"72","author":"EEII Leonard","year":"2004","unstructured":"Leonard EEII, Tompkins LS, Falkow S, Nachamkin I: Comparison of Campylobacter jejuni isolates implicated in Guillain-Barr\u00e9 syndrome and strains that cause enteritis by a DNA microarray. Infect Immun. 2004, 72: 1199-1203. 10.1128\/IAI.72.2.1199-1203.2004.","journal-title":"Infect Immun"},{"key":"245_CR19","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/89831","volume":"7","author":"A van Belkum","year":"2001","unstructured":"van Belkum A, van den Braak N, Godschalk P, Ang W, Jacobs B, Gilbert M, Wakarchuk W, Verbrugh H, Endtz H: A Campylobacter jejuni gene associated with immune-mediated neuropathy. Nat Med. 2001, 7: 752-753. 10.1038\/89831.","journal-title":"Nat Med"},{"key":"245_CR20","doi-asserted-by":"publisher","first-page":"5299","DOI":"10.1128\/IAI.70.9.5299-5303.2002","volume":"70","author":"I Nachamkin","year":"2002","unstructured":"Nachamkin I, Liu J, Li M, Ung H, Moran AP, Prendergast MM, Sheikh K: Campylobacter jejuni from patients with Guillain-Barr\u00e9 syndrome preferentially expresses a GD1a-like epitope. Infect Immun. 2002, 70: 5299-5303. 10.1128\/IAI.70.9.5299-5303.2002.","journal-title":"Infect Immun"},{"key":"245_CR21","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1172\/JCI200415707","volume":"114","author":"PCR Godschalk","year":"2004","unstructured":"Godschalk PCR, Heikema AP, Gilbert M, Komagamine T, Ang CW, Glerum J, Brochu D, Li J, Yuki N, Jacobs BC, van Belkum A, Endtz HP: The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barr\u00e9 syndrome. J Clin Invest. 2004, 114: 1659-1665. 10.1172\/JCI200415707.","journal-title":"J Clin Invest"},{"key":"245_CR22","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1212\/01.wnl.0000176914.70893.14","volume":"65","author":"M Koga","year":"2005","unstructured":"Koga M, Takahashi M, Masuda M, Hirata K, Yuki N: Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barr\u00e9 syndrome. Neurology. 2005, 65: 1376-1381.","journal-title":"Neurology"},{"key":"245_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1128\/JCM.39.1.14-23.2001","volume":"39","author":"KE Dingle","year":"2001","unstructured":"Dingle KE, Colles FM, Wareing DRA, Ure R, Fox AJ, Bolton FE, Bootsma HJ, Willems RJL, Urwin R, Maiden MCJ: Multilocus sequence typing system for Campylobacter jejuni. J Clin Microbiol. 2001, 39: 14-23. 10.1128\/JCM.39.1.14-23.2001.","journal-title":"J Clin Microbiol"},{"key":"245_CR24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0034-5288(96)90013-2","volume":"60","author":"RD Ayling","year":"1996","unstructured":"Ayling RD, Woodward MJ, Evans S, Newell DG: Restriction fragment length polymorphism of polymerase chain reaction products applied to the differentiation of poultry Campylobacters for epidemiological investigations. Res Vet Sci. 1996, 60: 168-172. 10.1016\/S0034-5288(96)90013-2.","journal-title":"Res Vet Sci"},{"key":"245_CR25","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1128\/AEM.65.6.2369-2375.1999","volume":"65","author":"B Duim","year":"1999","unstructured":"Duim B, Wassenaar TM, Rigter A, Wagenaar J: High-resolution genotyping of Campylobacter strains isolated from poultry and humans with amplified fragment length polymorphism fingerprinting. Appl Environ Microbiol. 1999, 65: 2369-2375.","journal-title":"Appl Environ Microbiol"},{"key":"245_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.mimet.2003.09.018","volume":"56","author":"N van den Braak","year":"2004","unstructured":"van den Braak N, Simons G, Gorkink R, Reijans M, Eadie K, Kremers K, van Soolingen D, Savelkoul P, Verbrugh H, van Belkum A: A new high-throughput AFLP approach for identification of new genetic polymorphism in the genome of the clonal microorganism Mycobacterium tuberculosis. J Microbiol Methods. 2004, 56: 49-62. 10.1016\/j.mimet.2003.09.018.","journal-title":"J Microbiol Methods"},{"key":"245_CR27","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.1128\/AEM.66.9.3917-3923.2000","volume":"66","author":"B Duim","year":"2000","unstructured":"Duim B, Ang CW, Van Belkum A, Rigter A, Van Leeuwen NW, Endtz HP, Wagenaar JA: Amplified fragment length polymorphism analysis of Campylobacter jejuni strains isolated from chickens and from patients with gastroenteritis or Guillain-Barr\u00e9 or Miller Fisher syndrome. Appl Environ Microbiol. 2000, 66: 3917-3923. 10.1128\/AEM.66.9.3917-3923.2000.","journal-title":"Appl Environ Microbiol"},{"key":"245_CR28","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1172\/JCI200423083","volume":"114","author":"DC Melles","year":"2004","unstructured":"Melles DC, Gorkink RFJ, Boelens HAM, Snijders SV, Peeters JK, Moorhouse MJ, van der Spek PJ, van Leeuwen WB, Simons G, Verbrugh HA, van Belkum A: Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus. J Clin Invest. 2004, 114: 1732-1740. 10.1172\/JCI200423083.","journal-title":"J Clin Invest"},{"key":"245_CR29","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1128\/jcm.29.4.680-688.1991","volume":"29","author":"CM Patton","year":"1991","unstructured":"Patton CM, Wachsmuth IK, Evins GM, Kiehlbauch JA, Plikaytis BD, Troup N, Tompkins L, Lior H: Evaluation of 10 methods to distinguish epidemic-associated Campylobacter strains. J Clin Microbiol. 1991, 29: 680-688.","journal-title":"J Clin Microbiol"},{"key":"245_CR30","doi-asserted-by":"publisher","first-page":"20327","DOI":"10.1074\/jbc.M401134200","volume":"279","author":"CD Carrillo","year":"2004","unstructured":"Carrillo CD, Taboada E, Nash JHE, Lanthier P, Kelly J, Lau PC, Verhulp R, Mykytczuk O, Sy J, Findlay WA, Amoako K, Gomis S, Willson P, Austin JW, Potter A, Babiuk L, Allan B, Szymanski CM: Genome-wide expression analyses of Campylobacter jejuni NCTC11168 reveals coordinate regulation of motility and virulence by flhA. J Biol Chem. 2004, 279: 20327-20338. 10.1074\/jbc.M401134200.","journal-title":"J Biol Chem"},{"key":"245_CR31","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1128\/JB.186.2.503-517.2004","volume":"186","author":"EC Gaynor","year":"2004","unstructured":"Gaynor EC, Cawthraw S, Manning G, MacKichan JK, Falkow S, Newell DG: The genome-sequenced variant of Campylobacter jejuni NCTC 11168 and the original clonal clinical isolate differ markedly in colonization, gene expression, and virulence-associated phenotypes. J Bacteriol. 2004, 186: 503-517. 10.1128\/JB.186.2.503-517.2004.","journal-title":"J Bacteriol"},{"key":"245_CR32","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1128\/IAI.72.2.1162-1165.2004","volume":"72","author":"M Gilbert","year":"2004","unstructured":"Gilbert M, Godschalk PCR, Karwaski MF, Ang CW, van Belkum A, Li J, Wakarchuk WW, Endtz HP: Evidence for acquisition of the lipooligosaccharide biosynthesis locus in Campylobacter jejuni GB11, a strain isolated from a patient with Guillain-Barr\u00e9 syndrome, by horizontal exchange. Infect Immun. 2004, 72: 1162-1165. 10.1128\/IAI.72.2.1162-1165.2004.","journal-title":"Infect Immun"},{"key":"245_CR33","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1086\/513779","volume":"176","author":"FGA van der Mech\u00e9","year":"1997","unstructured":"van der Mech\u00e9 FGA, Visser LH, Jacobs BC, Endtz HP, Meulstee J, Van Doorn PA: Guillain-Barr\u00e9 syndrome: multifactorial mechanisms versus defined subgroups. J Infect Dis. 1997, 176: S99-102.","journal-title":"J Infect Dis"},{"key":"245_CR34","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1212\/WNL.43.10.1911","volume":"43","author":"A Chiba","year":"1993","unstructured":"Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I: Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barr\u00e9 syndrome: clinical and immunohistochemical studies. Neurology. 1993, 43: 1911-1917.","journal-title":"Neurology"},{"key":"245_CR35","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/ana.410400209","volume":"40","author":"BC Jacobs","year":"1996","unstructured":"Jacobs BC, Van Doorn PA, Schmitz PIM, Tio-Gillen AP, Herbrink P, Visser LH, Hooijkaas H, Van der Mech\u00e9 FGA: Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barr\u00e9 syndrome. Ann Neurol. 1996, 40: 181-187. 10.1002\/ana.410400209.","journal-title":"Ann Neurol"},{"key":"245_CR36","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1128\/IAI.70.3.1202-1208.2002","volume":"70","author":"CW Ang","year":"2002","unstructured":"Ang CW, Laman JD, Willison HJ, Wagner ER, Endtz HP, de Klerk MA, Tio-Gillen AP, van den Braak N, Jacobs BC, van Doorn PA: Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barr\u00e9 and Miller Fisher patients. Infect Immun. 2002, 70: 1202-1208. 10.1128\/IAI.70.3.1202-1208.2002.","journal-title":"Infect Immun"},{"key":"245_CR37","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/35001088","volume":"403","author":"J Parkhill","year":"2000","unstructured":"Parkhill J, Wren BW, Mungall K, Ketley JM, Churcher C, Basham D, Chillingworth T, Davies RM, Feltwell T, Holroyd S, Jagels K, Karlyshev AV, Moule S, Pallen MJ, Penn CW, Quail MA, Rajandream MA, Rutherford KM, van Vliet AH, Whitehead S, Barrell BG: The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature. 2000, 403: 665-668. 10.1038\/35001088.","journal-title":"Nature"},{"key":"245_CR38","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1093\/nar\/23.21.4407","volume":"23","author":"P Vos","year":"1995","unstructured":"Vos P, Hogers R, Bleeker M, Reijans M, van de Lee T, Hornes M, Frijters A, Pot J, Peleman J, Kuiper M: AFLP: a new technique for DNA fingerprinting. Nucleic Acids Res. 1995, 23: 4407-4414.","journal-title":"Nucleic Acids Res"},{"key":"245_CR39","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S0888-7543(03)00179-4","volume":"82","author":"M Reijans","year":"2003","unstructured":"Reijans M, Lascaris R, Groeneger AO, Wittenberg A, Wesselink E, van Oeveren J, Wit E, Boorsma A, Voetdijk B, van der Spek H: Quantitative comparison of cDNA-AFLP, microarrays, and genechip expression data in Saccharomyces cerevisiae. Genomics. 2003, 82: 606-618. 10.1016\/S0888-7543(03)00179-4.","journal-title":"Genomics"},{"key":"245_CR40","unstructured":"National Center for Biotechnology Information (NCBI) -BLAST website.http:\/\/www.ncbi.nlm.nih.gov\/BLAST\/"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2180-6-32.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T01:31:39Z","timestamp":1630459899000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/1471-2180-6-32"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,4]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["245"],"URL":"https:\/\/doi.org\/10.1186\/1471-2180-6-32","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,4]]},"assertion":[{"value":"19 October 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"32"}}